Viewing Study NCT06384560


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2025-12-29 @ 2:20 AM
Study NCT ID: NCT06384560
Status: RECRUITING
Last Update Posted: 2025-01-20
First Post: 2024-04-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Triple Treatment for Borderline Resectable Pancreatic Cancer (PREOPANC-5)
Sponsor:
Organization: